Patent details
EP3597179 Title: PHARMACEUTICAL DOSAGE FORMS
Basic Information
- Publication number:
- EP3597179
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP191812171
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL DOSAGE FORMS
- French Title of Invention:
- FORMULES DE DOSAGE PHARMACEUTIQUE
- German Title of Invention:
- DOSIERFORMEN FÜR ARZNEIMITTEL
- SPC Number:
Dates
- Filing date:
- 11/12/2014
- Grant date:
- 03/04/2024
- EP Publication Date:
- 22/01/2020
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/04/2024
- EP B1 Publication Date:
- 03/04/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 11/12/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/03/2024
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
- Name:
- RIBEIRO, Suzie
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 201361915606 P
- Priority Date:
- 13/12/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 35/00; A61P 43/00; A61K 9/16; A61K 9/48; A61K 31/506;
Publication
European Patent Bulletin
- Issue number:
- 202414
- Publication date:
- 03/04/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/06/2025
- Annual Fee Number:
- 11
- Annual Fee Amount:
- 148 Euro
- Penalty Fee Amount:
- 20 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|